BeOne Medicines AG (ONC) Financials

ONC Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 9.2 billion 4.0 billion
March 31, 2026 8.6 billion 3.8 billion
Dec. 31, 2025 8.2 billion 3.8 billion
Sept. 30, 2025 7.6 billion 3.5 billion

ONC Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 595.9 million 260.8 million
March 31, 2026 161.0 million 123.4 million
Dec. 31, 2025 131.3 million 757.1 million
Sept. 30, 2025 354.5 million 140.8 million

ONC Net Income

No data available :(

ONC Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 5.1 billion 882.2 million 70.2 million
March 31, 2026 4.8 billion 962.5 million 70.3 million
Dec. 31, 2025 4.5 billion 1.8 billion 52.9 million
Sept. 30, 2025 4.0 billion 139.6 million 67.1 million

ONC Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 115.8 million
March 31, 2026 115.8 million
Dec. 31, 2025 113.4 million
Sept. 30, 2025 114.5 million

ONC Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 68.3 million 612.3 million 593.2 million -
March 31, 2026 40.9 million 541.2 million 555.1 million -
Dec. 31, 2025 286.1 million 615.4 million 555.3 million -
Sept. 30, 2025 48.1 million 523.7 million 529.0 million -

ONC Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 1.7 billion 174.5 million
March 31, 2026 1.5 billion 167.2 million
Dec. 31, 2025 1.5 billion 142.4 million
Sept. 30, 2025 1.4 billion 196.5 million

ONC Revenue by Segment
Graph available only for paid members. Upgrade to see it.

ONC

Price: $376.86

52 week price:
253.95
385.22

Earnings Per Share: 5.60 USD

P/E Ratio: 64.16

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 40.6 billion

Links: